Skip to main content
. 2020 Sep 29;8(10):1236–1247. doi: 10.1177/2050640620957765

Table 2.

Results of the evaluation of faecal microbiota transplantation (FMT) requests by multidisciplinary FMT expert panel.

FMT decision Number of requests
FMT request rejected by NDFB expert panel 47/176 (27%)
Reasons of rejection of the 47 FMT requests:
C. difficile carriership and diarrhoea due to other cause; 30 (64%)
 • Diarrhoea with unknown cause –18
 • Diarrhoea due to IBD –12
Anti-CDI antibiotics advised instead of FMT; 11 (23%)
 • First, mild recurrence –7
 • New CDI infection (too long interval between CDI episodes) –4
Long-term antibiotic use/elective operation 3 (6%)
Withdrawal of FMT request after observed antibiotic treatment effect, by treating physician or patient 3 (6%)
Request for FMT approved by NDFB expert panel 129/176 (73%)
FMT indicationa
 • Multiple recurrent CDI 125 (97%)
 • Severe, therapy refractory CDI 3 (2%)
 • Refractory CDI 1 (1%)

CDI: Clostridioides difficile infection; IBD: inflammatory bowel disease.

aOne hundred and forty-three FMTs performed in 129 patients. Ten patients received multiple FMTs; nine patients for treatment of a post-FMT CDI relapse (seven patients cured with a single repeat FMT, one patient cured with two repeat FMTs, one patient cured with antibiotics after a repeat FMT) and one patient received sequential FMT treatment for severe, therapy refractory CDI (in total six FMTs; three FMTs for a first episode and three FMTs for the relapse).